OUTLOOK THERAPEUTICS INC (OTLK)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $100.54M
Last updated: Nov 17, 2026 at 11:05 AM ET
OUTLOOK THERAPEUTICS INC (OTLK) Stock Forecast
Analysts expect OUTLOOK THERAPEUTICS INC (OTLK) to earn -$0.12 per share in the fiscal year ending Sep 30, 2027, on revenue of $44.07M. Of 4 analysts, 3 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 2 estimates for the fiscal year ending Sep 30, 2027 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 2.25, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 75% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 3 | 75.0% |
| Hold | 1 | 25.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 4
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
- Fiscal year ending Sep 30, 2027
- -$0.12
- EPS consensus, revenue $44.07M
- Next report
- Dec 17, 2026
- Estimated
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Sep 30, 2027 | -$0.12 | -$0.27 to -$0.03 | 3 | $44.07M | $30.00M to $74.74M | 4 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.05 | -$0.08 to -$0.01 | 3 | $5.30M | $1.30M to $8.90M | 4 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 3 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Sep 30, 2027 | 2 | 0 |
| Quarter ending Dec 31, 2026 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Sep 30, 2027 has improved from -$0.22.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Sep 30, 2027 | -$0.12 | -$0.14 | -$0.16 | -$0.22 | -$0.22 | N/A |
| Quarter ending Dec 31, 2026 | -$0.05 | -$0.05 | -$0.05 | -$0.08 | -$0.08 | N/A |
Frequently Asked Questions About OTLK
What is the OTLK stock forecast?
Consensus analyst estimates put OUTLOOK THERAPEUTICS INC's EPS at -$0.12 for the fiscal year ending Sep 30, 2027, on revenue of $44.07M. The consensus rating from 4 analysts is Buy.
How do analysts rate OTLK stock?
Of 4 analysts covering OUTLOOK THERAPEUTICS INC, 0 rate it Strong Buy, 3 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from OTLK next year?
For the fiscal year ending Sep 30, 2027, the consensus EPS estimate is -$0.12, with estimates from -$0.27 to -$0.03 from 3 analysts.
What revenue do analysts expect from OUTLOOK THERAPEUTICS INC next year?
For the fiscal year ending Sep 30, 2027, the consensus revenue estimate is $44.07M, with estimates from $30.00M to $74.74M.
How many analysts cover OTLK?
4 analysts rate OUTLOOK THERAPEUTICS INC stock, and 3 analysts estimate its EPS for the fiscal year ending Sep 30, 2027.
OTLK pages: Overview, Earnings, Forecast, Financials, Competitors